The global market for Continuous Processing Lines for Pharma was valued at US$ 5090 million in the year 2023 and is projected to reach a revised size of US$ 7798 million by 2030, growing at a CAGR of 6.4% during the forecast period.
Continuous Processing Lines for Pharma refer to manufacturing systems that produce drugs in a steady, uninterrupted flow, as opposed to traditional batch processing. These systems integrate various stages of production, such as mixing, granulation, drying, and tablet compression, into a seamless, ongoing operation. Continuous processing offers advantages such as enhanced efficiency, higher product quality, reduced production time, and lower operational costs by minimizing downtime and improving consistency. It is particularly useful for large-scale production of pharmaceutical products, allowing for better scalability, real-time monitoring, and more efficient use of resources compared to batch-based methods.
North American market for Continuous Processing Lines for Pharma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Continuous Processing Lines for Pharma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Continuous Processing Lines for Pharma in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Continuous Processing Lines for Pharma include GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Continuous Processing Lines for Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Processing Lines for Pharma.
The Continuous Processing Lines for Pharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Processing Lines for Pharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Processing Lines for Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GEA Group
Glatt Group
IMA Group
LB Bohle
Hovione
Continuus Pharmaceuticals
Syntegon
Repligen
Dec Group
Recipharm
Shionogi
SK biotek
Korsch
Chemtrix
Fette Compacting
Gericke
Thermo Fisher Scientific
Coperion
Siemens
Copa-DATA
Asymchem Laboratories(Tianjin)
Porton Pharma Solutions
Zhejiang Canaan Tech
Segment by Type
Solid Dosage Forms
Liquid Dosage Forms
Segment by Application
Pharmaceutical Companies
Contract Manufacturing Organization
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Processing Lines for Pharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Processing Lines for Pharma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Solid Dosage Forms
1.2.3 Liquid Dosage Forms
1.3 Market by Application
1.3.1 Global Continuous Processing Lines for Pharma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Processing Lines for Pharma Market Perspective (2019-2030)
2.2 Global Continuous Processing Lines for Pharma Growth Trends by Region
2.2.1 Global Continuous Processing Lines for Pharma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Processing Lines for Pharma Historic Market Size by Region (2019-2024)
2.2.3 Continuous Processing Lines for Pharma Forecasted Market Size by Region (2025-2030)
2.3 Continuous Processing Lines for Pharma Market Dynamics
2.3.1 Continuous Processing Lines for Pharma Industry Trends
2.3.2 Continuous Processing Lines for Pharma Market Drivers
2.3.3 Continuous Processing Lines for Pharma Market Challenges
2.3.4 Continuous Processing Lines for Pharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Processing Lines for Pharma Players by Revenue
3.1.1 Global Top Continuous Processing Lines for Pharma Players by Revenue (2019-2024)
3.1.2 Global Continuous Processing Lines for Pharma Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Processing Lines for Pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Continuous Processing Lines for Pharma Revenue
3.4 Global Continuous Processing Lines for Pharma Market Concentration Ratio
3.4.1 Global Continuous Processing Lines for Pharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Processing Lines for Pharma Revenue in 2023
3.5 Global Key Players of Continuous Processing Lines for Pharma Head office and Area Served
3.6 Global Key Players of Continuous Processing Lines for Pharma, Product and Application
3.7 Global Key Players of Continuous Processing Lines for Pharma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Processing Lines for Pharma Breakdown Data by Type
4.1 Global Continuous Processing Lines for Pharma Historic Market Size by Type (2019-2024)
4.2 Global Continuous Processing Lines for Pharma Forecasted Market Size by Type (2025-2030)
5 Continuous Processing Lines for Pharma Breakdown Data by Application
5.1 Global Continuous Processing Lines for Pharma Historic Market Size by Application (2019-2024)
5.2 Global Continuous Processing Lines for Pharma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Processing Lines for Pharma Market Size (2019-2030)
6.2 North America Continuous Processing Lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Continuous Processing Lines for Pharma Market Size by Country (2019-2024)
6.4 North America Continuous Processing Lines for Pharma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Processing Lines for Pharma Market Size (2019-2030)
7.2 Europe Continuous Processing Lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Continuous Processing Lines for Pharma Market Size by Country (2019-2024)
7.4 Europe Continuous Processing Lines for Pharma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Processing Lines for Pharma Market Size (2019-2030)
8.2 Asia-Pacific Continuous Processing Lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Continuous Processing Lines for Pharma Market Size by Region (2019-2024)
8.4 Asia-Pacific Continuous Processing Lines for Pharma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Processing Lines for Pharma Market Size (2019-2030)
9.2 Latin America Continuous Processing Lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Continuous Processing Lines for Pharma Market Size by Country (2019-2024)
9.4 Latin America Continuous Processing Lines for Pharma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Processing Lines for Pharma Market Size (2019-2030)
10.2 Middle East & Africa Continuous Processing Lines for Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Continuous Processing Lines for Pharma Market Size by Country (2019-2024)
10.4 Middle East & Africa Continuous Processing Lines for Pharma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GEA Group
11.1.1 GEA Group Company Details
11.1.2 GEA Group Business Overview
11.1.3 GEA Group Continuous Processing Lines for Pharma Introduction
11.1.4 GEA Group Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.1.5 GEA Group Recent Development
11.2 Glatt Group
11.2.1 Glatt Group Company Details
11.2.2 Glatt Group Business Overview
11.2.3 Glatt Group Continuous Processing Lines for Pharma Introduction
11.2.4 Glatt Group Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.2.5 Glatt Group Recent Development
11.3 IMA Group
11.3.1 IMA Group Company Details
11.3.2 IMA Group Business Overview
11.3.3 IMA Group Continuous Processing Lines for Pharma Introduction
11.3.4 IMA Group Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.3.5 IMA Group Recent Development
11.4 LB Bohle
11.4.1 LB Bohle Company Details
11.4.2 LB Bohle Business Overview
11.4.3 LB Bohle Continuous Processing Lines for Pharma Introduction
11.4.4 LB Bohle Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.4.5 LB Bohle Recent Development
11.5 Hovione
11.5.1 Hovione Company Details
11.5.2 Hovione Business Overview
11.5.3 Hovione Continuous Processing Lines for Pharma Introduction
11.5.4 Hovione Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.5.5 Hovione Recent Development
11.6 Continuus Pharmaceuticals
11.6.1 Continuus Pharmaceuticals Company Details
11.6.2 Continuus Pharmaceuticals Business Overview
11.6.3 Continuus Pharmaceuticals Continuous Processing Lines for Pharma Introduction
11.6.4 Continuus Pharmaceuticals Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.6.5 Continuus Pharmaceuticals Recent Development
11.7 Syntegon
11.7.1 Syntegon Company Details
11.7.2 Syntegon Business Overview
11.7.3 Syntegon Continuous Processing Lines for Pharma Introduction
11.7.4 Syntegon Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.7.5 Syntegon Recent Development
11.8 Repligen
11.8.1 Repligen Company Details
11.8.2 Repligen Business Overview
11.8.3 Repligen Continuous Processing Lines for Pharma Introduction
11.8.4 Repligen Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.8.5 Repligen Recent Development
11.9 Dec Group
11.9.1 Dec Group Company Details
11.9.2 Dec Group Business Overview
11.9.3 Dec Group Continuous Processing Lines for Pharma Introduction
11.9.4 Dec Group Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.9.5 Dec Group Recent Development
11.10 Recipharm
11.10.1 Recipharm Company Details
11.10.2 Recipharm Business Overview
11.10.3 Recipharm Continuous Processing Lines for Pharma Introduction
11.10.4 Recipharm Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.10.5 Recipharm Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Details
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Continuous Processing Lines for Pharma Introduction
11.11.4 Shionogi Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.11.5 Shionogi Recent Development
11.12 SK biotek
11.12.1 SK biotek Company Details
11.12.2 SK biotek Business Overview
11.12.3 SK biotek Continuous Processing Lines for Pharma Introduction
11.12.4 SK biotek Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.12.5 SK biotek Recent Development
11.13 Korsch
11.13.1 Korsch Company Details
11.13.2 Korsch Business Overview
11.13.3 Korsch Continuous Processing Lines for Pharma Introduction
11.13.4 Korsch Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.13.5 Korsch Recent Development
11.14 Chemtrix
11.14.1 Chemtrix Company Details
11.14.2 Chemtrix Business Overview
11.14.3 Chemtrix Continuous Processing Lines for Pharma Introduction
11.14.4 Chemtrix Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.14.5 Chemtrix Recent Development
11.15 Fette Compacting
11.15.1 Fette Compacting Company Details
11.15.2 Fette Compacting Business Overview
11.15.3 Fette Compacting Continuous Processing Lines for Pharma Introduction
11.15.4 Fette Compacting Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.15.5 Fette Compacting Recent Development
11.16 Gericke
11.16.1 Gericke Company Details
11.16.2 Gericke Business Overview
11.16.3 Gericke Continuous Processing Lines for Pharma Introduction
11.16.4 Gericke Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.16.5 Gericke Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Continuous Processing Lines for Pharma Introduction
11.17.4 Thermo Fisher Scientific Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 Coperion
11.18.1 Coperion Company Details
11.18.2 Coperion Business Overview
11.18.3 Coperion Continuous Processing Lines for Pharma Introduction
11.18.4 Coperion Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.18.5 Coperion Recent Development
11.19 Siemens
11.19.1 Siemens Company Details
11.19.2 Siemens Business Overview
11.19.3 Siemens Continuous Processing Lines for Pharma Introduction
11.19.4 Siemens Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.19.5 Siemens Recent Development
11.20 Copa-DATA
11.20.1 Copa-DATA Company Details
11.20.2 Copa-DATA Business Overview
11.20.3 Copa-DATA Continuous Processing Lines for Pharma Introduction
11.20.4 Copa-DATA Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.20.5 Copa-DATA Recent Development
11.21 Asymchem Laboratories(Tianjin)
11.21.1 Asymchem Laboratories(Tianjin) Company Details
11.21.2 Asymchem Laboratories(Tianjin) Business Overview
11.21.3 Asymchem Laboratories(Tianjin) Continuous Processing Lines for Pharma Introduction
11.21.4 Asymchem Laboratories(Tianjin) Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.21.5 Asymchem Laboratories(Tianjin) Recent Development
11.22 Porton Pharma Solutions
11.22.1 Porton Pharma Solutions Company Details
11.22.2 Porton Pharma Solutions Business Overview
11.22.3 Porton Pharma Solutions Continuous Processing Lines for Pharma Introduction
11.22.4 Porton Pharma Solutions Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.22.5 Porton Pharma Solutions Recent Development
11.23 Zhejiang Canaan Tech
11.23.1 Zhejiang Canaan Tech Company Details
11.23.2 Zhejiang Canaan Tech Business Overview
11.23.3 Zhejiang Canaan Tech Continuous Processing Lines for Pharma Introduction
11.23.4 Zhejiang Canaan Tech Revenue in Continuous Processing Lines for Pharma Business (2019-2024)
11.23.5 Zhejiang Canaan Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
GEA Group
Glatt Group
IMA Group
LB Bohle
Hovione
Continuus Pharmaceuticals
Syntegon
Repligen
Dec Group
Recipharm
Shionogi
SK biotek
Korsch
Chemtrix
Fette Compacting
Gericke
Thermo Fisher Scientific
Coperion
Siemens
Copa-DATA
Asymchem Laboratories(Tianjin)
Porton Pharma Solutions
Zhejiang Canaan Tech
听
听
*If Applicable.
